{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:27:45Z","timestamp":1791656865838,"version":"4.3.4"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030_175585"],"award-info":[{"award-number":["320030_175585"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The currently recommended benzimidazole monotherapy is insufficiently effective to control infection with the soil-transmitted helminth Trichuris trichiura. Ivermectin-albendazole combination has shown promising, but setting-dependent efficacy, with therapeutic underperformance in C\u00f4te d\u2019Ivoire. We evaluated whether moxidectin-albendazole could serve as an alternative to albendazole monotherapy in C\u00f4te d\u2019Ivoire.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this community-based, randomized, placebo-controlled, parallel-group superiority trial, individuals aged 12\u201360 years were screened for T. trichiura eggs in their stool using quadruplicate Kato-Katz thick smears. Diagnostically and clinically eligible participants were randomly assigned (1:1:1) to receive single oral doses of moxidectin (8 mg) and albendazole (400 mg), ivermectin (200 \u00b5g\/kg) and albendazole (400 mg), or albendazole (400 mg) and placebo. The primary outcome was proportion cured, ie, cure rate (CR), assessed at 2\u20133 weeks post-treatment. Safety endpoints were assessed pre-treatment and at 3 and 24 hours post-treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>For the 210 participants with primary outcome data, we observed CRs of 15.3% in the moxidectin-albendazole arm and 22.5% in the ivermectin-albendazole arm, which did not differ significantly from the CR of 13.4% in the albendazole arm (differences: 1.8%-points [95% confidence interval: \u221210.1 to 13.6] and 9.1%-points [\u22123.9 to 21.8], respectively). Most common adverse events were abdominal pain (range across arms: 11.9%\u201320.9%), headache (4.7%\u201314.3%), and itching (5.8%\u201313.1%), which were predominantly mild and transient.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>All therapies showed similar low efficacy in treating trichuriasis in C\u00f4te d\u2019Ivoire. Alternative treatment options need to be evaluated, and further analyses should be conducted to understand the lack of enhanced activity of the combination therapies in C\u00f4te d\u2019Ivoire.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Trials Registration<\/jats:title>\n                  <jats:p>NCT04726969.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciad387","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T16:38:16Z","timestamp":1687624696000},"page":"1294-1302","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy and Safety of Moxidectin-Albendazole and Ivermectin-Albendazole Combination Therapy Compared to Albendazole Monotherapy in Adolescents and Adults Infected with <i>Trichuris trichiura<\/i>: A Randomized, Controlled Superiority Trial"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1558-6687","authenticated-orcid":false,"given":"Viviane P","family":"Sprecher","sequence":"first","affiliation":[{"name":"Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute (Swiss TPH) , Allschwil , Switzerland"},{"name":"University of Basel , Basel , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3626-6068","authenticated-orcid":false,"given":"Jean T","family":"Coulibaly","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Formation et de Recherche Biosciences, Universit\u00e9 F\u00e9lix Houphou\u00ebt-Boigny , Abidjan , C\u00f4te d\u2019Ivoire"},{"name":"Centre Suisse de Recherches Scientifiques en C\u00f4te d\u2019Ivoire , Abidjan , C\u00f4te d\u2019Ivoire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-8198","authenticated-orcid":false,"given":"Eveline","family":"H\u00fcrlimann","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute (Swiss TPH) , Allschwil , Switzerland"},{"name":"University of Basel , Basel , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1176-401X","authenticated-orcid":false,"given":"Jan","family":"Hattendorf","sequence":"additional","affiliation":[{"name":"University of Basel , Basel , Switzerland"},{"name":"Department of Epidemiology and Public Health , Swiss Tropical and Public Health Institute (Swiss TPH), Allschwil , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0290-3521","authenticated-orcid":false,"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute (Swiss TPH) , Allschwil , Switzerland"},{"name":"University of Basel , Basel , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"2023111209203688800_ciad387-B1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1756-3305-7-37","article-title":"Global numbers of infection and disease burden of soil transmitted helminth infections in 2010","volume":"7","author":"Pullan","year":"2014","journal-title":"Parasit Vectors"},{"key":"2023111209203688800_ciad387-B2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(17)31930-X","article-title":"Soil-transmitted helminth infections","volume":"391","author":"Jourdan","year":"2018","journal-title":"Lancet"},{"key":"2023111209203688800_ciad387-B3","volume-title":"2030 targets for soil-transmitted helminthiases control programmes","author":"World Health Organization","year":"2019"},{"key":"2023111209203688800_ciad387-B4","volume-title":"Model list of essential medicines, 22nd list","author":"World Health Organization","year":"2021"},{"key":"2023111209203688800_ciad387-B5","doi-asserted-by":"crossref","first-page":"j4307","DOI":"10.1136\/bmj.j4307","article-title":"Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis","volume":"358","author":"Moser","year":"2017","journal-title":"BMJ"},{"key":"2023111209203688800_ciad387-B6","first-page":"96","article-title":"Efficacy of anthelminthic drugs and drug combinations against soil-transmitted helminths: a systematic review and network meta-analysis","volume":"68","author":"Clarke","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023111209203688800_ciad387-B7","volume-title":"The selection and use of essential medicines\u2014report of the WHO Expert Committee, 2017 (including the 20th WHO model list of essential medicines and the 6th model list of essential medicines for children)","author":"World Health Organization","year":"2017"},{"key":"2023111209203688800_ciad387-B8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006458","article-title":"Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: a systematic review, meta-analysis and individual patient data analysis","volume":"12","author":"Palmeirim","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2023111209203688800_ciad387-B9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1473-3099(21)00421-7","article-title":"Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in C\u00f4te d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial","volume":"22","author":"H\u00fcrlimann","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023111209203688800_ciad387-B10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0020-7519(01)00174-6","article-title":"Selection of different genotype larvae and adult worms for anthelmintic resistance by persistent and short-acting avermectin\/milbemycins","volume":"31","author":"Barnes","year":"2001","journal-title":"Int J Parasitol"},{"key":"2023111209203688800_ciad387-B11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijpddr.2011.09.002","article-title":"Is anthelmintic resistance a concern for the control of human soil-transmitted helminths?","volume":"1","author":"Vercruysse","year":"2011","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2023111209203688800_ciad387-B12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpddr.2019.06.002","article-title":"Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance","volume":"10","author":"Prichard","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2023111209203688800_ciad387-B13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(17)32844-1","article-title":"Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial","volume":"392","author":"Opoku","year":"2018","journal-title":"Lancet"},{"key":"2023111209203688800_ciad387-B14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1473-3099(18)30233-0","article-title":"Efficacy and tolerability of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole plus oxantel pamoate against Trichuris trichiura infections: a randomised, non-inferiority, single-blind trial","volume":"18","author":"Barda","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2023111209203688800_ciad387-B15","first-page":"1193","article-title":"Efficacy and safety of ascending dosages of moxidectin and moxidectin-albendazole against Trichuris trichiura in adolescents: a randomized controlled trial","volume":"70","author":"Keller","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023111209203688800_ciad387-B16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1473-3099(22)00589-8","article-title":"Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with Trichuris trichiura in Tanzania: an open-label, non-inferiority, randomised, controlled, phase 2\/3 trial","volume":"23","author":"Welsche","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023111209203688800_ciad387-B17","volume-title":"WMA Declaration of Helsinki\u2014ethical principles for medical research involving human subjects","author":"World Medical Association","year":"2013"},{"key":"2023111209203688800_ciad387-B18","author":"International Council for Harmonization","year":"2016"},{"key":"2023111209203688800_ciad387-B19","volume-title":"Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee","author":"World Health Organization","year":"2002"},{"key":"2023111209203688800_ciad387-B20"},{"key":"2023111209203688800_ciad387-B21","first-page":"377","article-title":"Research electronic data capture (REDCap)","volume":"42","author":"Harris","year":"2009","journal-title":"\u2014"},{"key":"2023111209203688800_ciad387-B22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap Consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2023111209203688800_ciad387-B23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006897","article-title":"Update on the current status of onchocerciasis in Cote d'Ivoire following 40 years of intervention: progress and challenges","volume":"12","author":"Koudou","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2023111209203688800_ciad387-B24","doi-asserted-by":"crossref","first-page":"e2247","DOI":"10.1371\/journal.pntd.0002247","article-title":"Association between response to albendazole treatment and \u03b2-tubulin genotype frequencies in soil-transmitted helminths","volume":"7","author":"Diawara","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2023111209203688800_ciad387-B25","first-page":"440","article-title":"Exploring the genetic differences among populations of Trichuris trichiura from Laos, Tanzania and Cote d'Ivoire with differing responses to albendazole-ivermectin combination treatment","volume":"105","author":"Venkatesan","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"2023111209203688800_ciad387-B26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eclinm.2018.06.004","article-title":"Efficacy and safety of a single dose versus a multiple dose regimen of mebendazole against hookworm infections in children: a randomised, double-blind trial","volume":"1","author":"Palmeirim","year":"2018","journal-title":"EClinicalMedicine"},{"key":"2023111209203688800_ciad387-B27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s40265-021-01505-1","article-title":"Preclinical and clinical characteristics of the trichuricidal drug oxantel pamoate and clinical development plans: a review","volume":"81","author":"Palmeirim","year":"2021","journal-title":"Drugs"},{"key":"2023111209203688800_ciad387-B28","volume-title":"Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups","author":"World Health Organization","year":"2017"},{"key":"2023111209203688800_ciad387-B29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010810","article-title":"Modeling the effect of different drugs and treatment regimen for hookworm on cure and egg reduction rates taking into account diagnostic error","volume":"16","author":"Grolimund","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2023111209203688800_ciad387-B30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s13071-020-04401-x","article-title":"Performance of the Kato-Katz method and real time polymerase chain reaction for the diagnosis of soil-transmitted helminthiasis in the framework of a randomised controlled trial: treatment efficacy and day-to-day variation","volume":"13","author":"Keller","year":"2020","journal-title":"Parasit Vectors"},{"key":"2023111209203688800_ciad387-B31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009134","article-title":"Quantitative PCR in soil-transmitted helminth epidemiology and control programs: toward a universal standard","volume":"15","author":"Cools","year":"2021","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad387\/51040314\/ciad387.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/9\/1294\/53302459\/ciad387.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/9\/1294\/53302459\/ciad387.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T09:20:59Z","timestamp":1699780859000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/77\/9\/1294\/7207508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,6,26]]},"published-print":{"date-parts":[[2023,11,11]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad387","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2023,6,26]]}}}